IGC Pharma, Inc.
IGCAMEXHealthcare● Active
$0.29
$-0.01(-2.14%)
Market Cap$29286627
P/E Ratio—
52W High$0.5
52W Low$0.24
IGC Pharma, Inc.（IGC）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IGC · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.19M | $1.27M | $1.34M | $0.91M | $0.40M |
| Cost of Revenue | $0.83M | $0.65M | $0.61M | $1.07M | $0.20M |
| Gross Profit | $0.35M | $0.62M | $0.73M | ($0.16M) | $0.19M |
| Gross Margin %(computed) | 29.68% | 48.70% | 54.50% | -17.34% | 48.87% |
| Operating Expenses | |||||
| R&D Expenses | $5.19M | $3.65M | $3.77M | $3.46M | $2.33M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $10.55M | $8.06M | $10.53M | $11.41M | $15.62M |
| Operating Income | ($10.20M) | ($7.45M) | ($9.80M) | ($11.57M) | ($15.43M) |
| Operating Margin %(computed) | -860.29% | -585.84% | -728.48% | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($6.55M) | ($7.12M) | ($13.00M) | ($11.51M) | ($15.02M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($6.55M) | ($7.12M) | ($13.00M) | ($11.51M) | ($15.02M) |
| Net Margin %(computed) | -552.11% | -560.27% | -966.54% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.07 | $-0.09 | $-0.22 | $-0.22 | $-0.30 |
| Wtd Avg Shares | 95.04M | 76.52M | 58.84M | 52.58M | 49.99M |
| EBITDA | ($9.88M) | ($6.98M) | ($9.16M) | ($10.85M) | ($14.37M) |
| EBITDA Margin %(computed) | -832.97% | -549.33% | -681.12% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解IGC Pharma, Inc.
关于IGC Pharma, Inc.（IGC）损益表
IGC Pharma, Inc.（IGC）损益表数据来源于SEC Form 10-K及10-Q申报文件。2026财年，IGC实现营收$0.00B，毛利润$0.00B（毛利率29.68%），净利润($0.01B)（净利率-552.11%）。
常见问题
IGC · 4 问IGC Pharma, Inc.（IGC）2026财年营收为$0.00B，同比down6.7%。
IGC revenueIGC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09